Moficept S 360mg Tablet

About

Moficept S 360mg Tablet contains Mycophenolate Sodium, an enteric-coated formulation of mycophenolic acid (MPA), a potent immunosuppressant. It is primarily indicated for the prophylaxis of organ rejection in adult patients receiving allogeneic kidney, heart, or liver transplants. Mycophenolate sodium functions by selectively inhibiting inosine monophosphate dehydrogenase (IMPDH), an enzyme crucial for the de novo synthesis of guanosine nucleotides. This targeted inhibition specifically suppresses the proliferation and function of T and B lymphocytes, which are the primary mediators of the immune response responsible for transplant rejection.

The enteric coating is designed to minimize gastrointestinal side effects by preventing the drug from dissolving in the stomach, allowing it to be released in the small intestine. This formulation aims to improve patient tolerability and adherence to therapy. By effectively modulating the immune system, Moficept S helps to ensure the long-term acceptance and survival of the transplanted organ, thereby improving patient outcomes and quality of life. It is typically used as part of a multi-drug immunosuppressive regimen, requiring careful clinical and laboratory monitoring.

Uses

• Prevention of kidney transplant rejection
• Prevention of heart transplant rejection
• Prevention of liver transplant rejection
• Treatment of lupus nephritis (off-label)

Directions For Use

Take orally on an empty stomach, as directed by your transplant physician. Do not crush or chew the tablet.

Benefits

• Effectively prevents organ transplant rejection
• Reduced gastrointestinal side effects due to enteric coating
• Improves long-term graft survival rates
• Allows for reduction in corticosteroid dosage
• Targeted immunosuppression of lymphocytes
• Well-established efficacy in transplant medicine

Side Effects

• Diarrhea
• Nausea
• Vomiting
• Abdominal pain
• Leukopenia (low white blood cell count)
• Anemia
• Thrombocytopenia (low platelet count)
• Increased risk of infections
• Hypertension
• Headache
• Tremor
• Insomnia

Safety Measures

• Alcohol - Avoid or limit alcohol consumption due to potential for increased gastrointestinal side effects and possible liver toxicity.
• Pregnancy - Contraindicated; causes birth defects. Women of childbearing potential must use effective contraception before, during, and after treatment.
• Breastfeeding - Contraindicated; excreted in breast milk and can cause serious adverse effects in the infant.
• Liver - Use with caution in severe liver impairment; dosage adjustments may be necessary. Monitor liver function closely.
• Kidney - Dosage adjustments may be required in severe renal impairment; monitor renal function and drug levels closely.
• Lung - Increased risk of opportunistic lung infections (e.g., Pneumocystis pneumonia); monitor for respiratory symptoms and consider prophylaxis.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.